This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Vale stands out as Bull of the Day after a strong turnaround, rising production and a nearly 7% dividend push shares to new highs.
Bear of the Day: Azenta (AZTA)
by Shaun Pruitt
2025 was another turbulent year for Azenta (AZTA) stock, which fell more than 30% as the medical solutions provider struggled with ongoing sales weakness.
New Strong Sell Stocks for December 30th
by Zacks Equity Research
ASBFY, AZTA and ALG have been added to the Zacks Rank #5 (Strong Sell) List on December 30, 2025.
New Strong Sell Stocks for Dec. 15
by Zacks Equity Research
ALG, AZTA and CMG have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 15, 2025.
New Strong Sell Stocks for December 9th
by Zacks Equity Research
BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.
Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Outset Medical (OM) delivered earnings and revenue surprises of -7.81% and -3.19%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
TruBridge (TBRG) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
TruBridge (TBRG) delivered earnings and revenue surprises of +120.00% and +1.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates
by Zacks Equity Research
Senseonics (SENS) delivered earnings and revenue surprises of -30.30% and +1.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell?
by Sridatri Sarkar
Tempus AI posts 89.6% Q2 revenue growth, raises 2025 sales outlook again, and sees positive adjusted EBITDA ahead. What is the investment outlook?
Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?
by Zacks Equity Research
Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately.